DXS International plc (DXSP) Ordinary 0.33p

Sell:2.00pBuy:2.20p0.75p (33.33%)

Prices delayed by at least 15 minutes
Sell:2.00p
Buy:2.20p
Change:0.75p (33.33%)
Prices delayed by at least 15 minutes
Sell:2.00p
Buy:2.20p
Change:0.75p (33.33%)
Prices delayed by at least 15 minutes

Company Information

About this company

DXS International plc is a digital clinical decision support company. The Company’s principal activities include the development and distribution of clinical decision support to general practitioners, nurses and retail pharmacies in the United Kingdom and South Africa. The commercial side includes the licensing of DXS products to various ICBs, the sale of e-detailing opportunities to the pharmaceutical industry, the United Kingdom primary care sector and the licensing of DXS technology to healthcare publishers. Its products include SMART Referral Solution and ExpertCare. Its SMART Referral Solution is a cloud-based clinical decision support system designed to enhance the accuracy, efficiency, and sustainability of healthcare referrals within the NHS and beyond. ExpertCare is a medicine optimization tool which promotes adherence with NICE guidelines on the management of hypertension and its comorbidities.

Key people

David Immelman
Chief Executive Officer, Founder, Director
Steven Bauer
Chief Operating Officer, Director
Colin Morgan
Secretary
Robert Keith Sutcliffe
Non-Executive Chairman of the Board
Click to see more

Key facts

  • EPIC
    DXSP
  • Location
    United Kingdom
  • Sector
    Technology
  • Industry
    Software & Programming
  • ISIN
    GB00B2Q6HZ92
  • Market cap
    £1.44m
  • Employees
    71
  • Shares in issue
    64.02m
  • Exchange
    Aquis Stock Exchange
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.